Thirty Madison
PrivateLast Round
Series C
Jun 2, 2021
Est. Valuation
$1B
Total Funding Raised
$228.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Thirty Madison is a healthtech company that provides personalized treatments and virtual care for chronic conditions through its portfolio of specialized brands.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, D2C Brands, Subscription Commerce, Patient Engagement
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thirty Madison Comparables
Compare Thirty Madison with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hims & Hers Health, Inc. | 87% | |
| Ro | 84% | |
| LifeMD Inc | 82% |
Thirty Madison Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 2, 2021 | ||||
| Series B | Aug 14, 2020 | ||||
| Series A | Oct 16, 2018 | ||||
| Seed | Nov 1, 2017 |
Key People
Founding team and executive leadership
Thirty Madison Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Two River Group | Series A |
| Maveron | Seed, Series B, Series A |
| Entrepreneurs Roundtable Accelerator | Series A |
| Bracket Capital | Series C |
| Cyrus Investments | Series C, Series B |
| Northzone | Series C, Series B, Series A |
| HillCour | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 40% MoM, reaching 7.2K.
- Jun 2, 2021
$140M round led by HealthQuest Capital
Thirty Madison Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Thirty Madison's valuation, stock price, and market status.
Is Thirty Madison a public or private company?
Thirty Madison is a private company.
What is the current stock price of Thirty Madison?
Thirty Madison is a private company with no public stock price. No recent secondary market data is available.
How much is Thirty Madison worth (valuation)?
Thirty Madison's valuation is estimated at $1.0B based on funding round data.
Can I buy Thirty Madison stock?
Thirty Madison shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Thirty Madison's last funding round?
Thirty Madison's most recent funding round was Series C on June 2, 2021.
Who are the main investors in Thirty Madison?
Key investors in Thirty Madison include Maveron, Northzone, Polaris Partners, Johnson & Johnson Innovation - JJDC, Inc., HealthQuest Capital.
Will Thirty Madison IPO soon?
No public IPO plans have been announced for Thirty Madison.
How can I track Thirty Madison secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Thirty Madison's secondary market activity and sign up for updates.